• All
  • Events
  • News
  • Press
  • Uncategorized
  • Video

TreeFrog Therapeutics receives additional €3M non-dilutive funding to mass-produce clinical-grade cell therapies by 2021 Company awarded close to €3M ($3.3M) in public grants only five months after Series A round of €7M ($7.8M) Bordeaux, France, September 5, 2019 – TreeFrog Therapeutics, an expert stem cell company, today announces...